Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00297492 · ClinicalTrials.gov registry record · Phase 2
Gradual vs. Abrupt Cessation Treatment for Smoking
A Phase 2 study, sponsored by University of Vermont.
- Completed
- Registry status
- Phase 2
- Development phase
- 750
- Enrollment target
NCT00297492 is a Phase 2 study that has completed, run by University of Vermont. The registered enrollment target is 750 participants.
The verdict
NCT00297492, a Phase 2 study, has completed, sponsored by University of Vermont.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 750 participants
- Enrollment target
Study Summary
This study tests whether stopping smoking by gradually cutting down first is more or less successful than stopping abruptly. We hypothesize that stopping by gradually cutting down first will produce more abstinence than stopping abruptly.
Interventions
- BEHAVIORAL Reduction Phone Counseling
- BEHAVIORAL Abrupt Phone Counseling
- BEHAVIORAL Minimal Abrupt Phone Counseling
- DRUG Pre-Quit Nicotine Lozenges
- DRUG Post-Quit Nicotine Lozenges
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2006-01 |
| Est. Completion | 2008-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00297492
The ClinicalTrials.gov registry entry for NCT00297492 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 750 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Vermont, which has 162 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Reduction Phone Counseling is the first listed.
NCT00297492 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00297492 about?
NCT00297492 is a clinical study titled "Gradual vs. Abrupt Cessation Treatment for Smoking". This study tests whether stopping smoking by gradually cutting down first is more or less successful than stopping abruptly. We hypothesize that stopping by gradually cutting down first will produce more abstinence than stopping abruptly.
What is the current status of trial NCT00297492?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 750 participants. The study started on 2006-01. Estimated completion is 2008-02.
What interventions are being tested in trial NCT00297492?
The interventions under investigation include: Reduction Phone Counseling (BEHAVIORAL), Abrupt Phone Counseling (BEHAVIORAL), Minimal Abrupt Phone Counseling (BEHAVIORAL), Pre-Quit Nicotine Lozenges (DRUG), Post-Quit Nicotine Lozenges (DRUG).
Who is sponsoring clinical trial NCT00297492?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.